1. Acknowledgement

   Acknowledgments 23 August 2012 Pages: 257 - 257

2. The Pharmaceutical Medicine Year that Was

   • Anthony W. Fox

   Commentary 23 August 2012 Pages: 259 - 261

3. Preparing for Regulatory Review and Reimbursement Decisions

   • Lawrence E. Liberti
   • Franz Pichler
   • Stuart R. Walker

   Editorial 23 August 2012 Pages: 263 - 267

   

4. A Reflection on Fraud and Misconduct in Biomedical Research

   • Frank Wells

   Editorial 23 August 2012 Pages: 269 - 272

5. Xenoestrogens

   • Ian Shaw
   • Lisa A. Graham

   Editorial 23 August 2012 Pages: 273 - 274

   

6. From the Seven Deadly Sins to a Risk Management Plan

   • Ambrogio Bottoni

   Editorial 23 August 2012 Pages: 275 - 277

7. Pharmacoeconomics in Healthcare Decision Making in China

   • Hai-tao Li
   • Ai-xia Ma
   • Shi-xue Li

   Current Opinion 23 August 2012 Pages: 279 - 282

8. Surrogate Efficacy Endpoints in Oncology Trials

   • Maurie Markman

   Current Opinion 23 August 2012 Pages: 283 - 287

   

9. Strategies to Measure and Improve Patient Adherence in Clinical Trials

   • Doreen Matsui

   Review Article 23 August 2012 Pages: 289 - 297

   

10. Interpersonal Values of Healthy Subjects Who Volunteer for Phase I Clinical Trials

    • Luis Almeida
    • Manuel Vaz-da-Silva
    • Patrício Soares-da-Silva

    Original Research Article 23 August 2012 Pages: 299 - 303

    

11. Key Performance Indicators of Clinical Trials in Japan

    • Michinori Terada
    • Mamoru Narukawa
    • Masahiro Takeuchi

    Original Research Article 23 August 2012 Pages: 305 - 308

    

12. 2nd Annual New Zealand Pharmaceutical Management Agency Forum

    • Christopher I. Carswell

    Meeting Report 23 August 2012 Pages: 309 - 310

13. Forum

    Update 23 August 2012 Pages: 311 - 329

14. Journal Watch

    Update 23 August 2012 Pages: 331 - 348

15. Major Pharmaceutical Conferences

    Update 23 August 2012 Pages: 349 - 351